Free Trial

Quoin Pharmaceuticals (QNRX) Institutional Ownership

Quoin Pharmaceuticals logo
$0.32 -0.01 (-4.06%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$0.32 +0.00 (+1.16%)
As of 02/21/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Quoin Pharmaceuticals (NASDAQ:QNRX)

Current
Institutional Ownership
Percentage
8.63%
Number of
Institutional Buyers
(last 12 months)
5
Total
Institutional Inflows
(last 12 months)
$378.91K
Number of
Institutional Sellers
(last 12 months)
0
Get QNRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Quoin Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

QNRX Institutional Buying and Selling by Quarter

Quoin Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/14/2025 Boothbay Fund Management LLC80,712$53K0.0%N/A1.598%
2/14/2025 Altium Capital Management LLC282,249$184K0.1%N/A5.589%
2/13/2025 Renaissance Technologies LLC133,122$87K0.0%+244.1%2.636%
1/28/2025 Apollon Wealth Management LLC80,025$52K0.0%N/A1.585%
5/20/2024 Virtu Financial LLC30,749$29K0.0%N/A0.773%
5/1/2023 Virtu Financial LLC147,907$70K0.0%N/A3.050%
11/7/2022 Virtu Financial LLC29,865$67K0.0%N/A2.948%
(Data available from 1/1/2016 forward)

QNRX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of QNRX shares?

During the previous two years, the following institutional investors and hedge funds held shares of Quoin Pharmaceuticals shares: Altium Capital Management LLC ($184K), Renaissance Technologies LLC ($87K), Boothbay Fund Management LLC ($53K), and Apollon Wealth Management LLC ($52K), Virtu Financial LLC ($29K).Learn more on QNRX's institutional investors.

What percentage of Quoin Pharmaceuticals stock is owned by institutional investors?

8.63% of Quoin Pharmaceuticals stock is owned by institutional investors. Learn more on QNRX's institutional investor holdings.

Which institutional investors have been buying Quoin Pharmaceuticals stock?

The following institutional investors have purchased Quoin Pharmaceuticals stock in the last 24 months: Altium Capital Management LLC ($282.25K), Virtu Financial LLC ($178.66K), Renaissance Technologies LLC ($94.43K), Boothbay Fund Management LLC ($80.71K), and Apollon Wealth Management LLC ($80.03K).

How much institutional buying is happening at Quoin Pharmaceuticals?

Institutional investors have bought a total of 716,073 shares in the last 24 months. This purchase volume represents approximately $1.22M in transactions.



This page (NASDAQ:QNRX) was last updated on 2/23/2025 by MarketBeat.com Staff
From Our Partners